Simultaneous Presentation of B-Acute Lymphoblastic Leukemia and Streptococcus agalactiae Meningitis in a 3-Year-old Girl

J Pediatr Hematol Oncol. 2024 Aug 1;46(6):e448-e452. doi: 10.1097/MPH.0000000000002921. Epub 2024 Jul 5.

Abstract

Infection is a major cause of treatment-related morbidity and mortality in pediatric acute lymphoblastic leukemia (ALL). Most children with ALL who develop life-threatening bacterial infections do so during induction therapy. We describe a rare case of ALL presenting simultaneously with Streptococcus agalactiae group B Streptococcus bacteremia and meningitis in a 3-year-old girl. She received appropriate antimicrobial therapy and a 2-drug early induction regimen consisting of vincristine and dexamethasone, leading to slow neurologic recovery and a favorable initial response to anti-neoplastic therapy as evidenced by minimal residual disease of 1.12% on day 15 of induction.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / microbiology
  • Child, Preschool
  • Dexamethasone* / administration & dosage
  • Dexamethasone* / therapeutic use
  • Female
  • Humans
  • Meningitis, Bacterial / diagnosis
  • Meningitis, Bacterial / drug therapy
  • Meningitis, Bacterial / microbiology
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / complications
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Streptococcal Infections* / drug therapy
  • Streptococcal Infections* / microbiology
  • Streptococcus agalactiae*
  • Vincristine / administration & dosage
  • Vincristine / therapeutic use

Substances

  • Dexamethasone
  • Vincristine